Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15962414 | 0.70 | CA1 (0.33) | RAB9AALDH1A1MAPT | |
| SCHEMBL9940386 | 0.69 | RAB9A (0.35) | ACHERAB9A | |
| SCHEMBL3938679 | 0.69 | CA1 (0.36) | — | |
| SCHEMBL4017179 | 0.67 | ELANE (0.40) | ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL11547215 | 0.66 | CA1 (0.33) | — | |
| SCHEMBL30367668 | 0.64 | ACHE (0.34) | ACHE | |
| SCHEMBL4435103 | 0.64 | — | — | |
| SCHEMBL4773759 | 0.63 | NPC1 (0.37) | ACHENPC1RAB9A | |
| SCHEMBL14648615 | 0.63 | CA1 (0.31) | — | |
| SCHEMBL3686517 | 0.62 | NQO1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1608612-B1 | PROCESS FOR PRODUCING CYCLOHEXENONE LONG-CHAIN ALCOHOLS | MEIJI DAIRIES CORP (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-7235700-B2 | cyclohexenone long-chain alcohol has a low molecular weight and is known to be useful as a prophylactic or therapeutic drug for cerebral diseases such as dementia | MEIJI DAIRIES CORPORATION (JP) | 2007-06-26 | — | — | US | disclosed |
| US-20060135818-A1 | Process for producing cyclohexenone long-chain alcohols | MEIJI DAIRIES CORPORATION | 2006-06-22 | — | — | US | disclosed |
| EP-1608612-A1 | PROCESS FOR PRODUCING CYCLOHEXENONE LONG-CHAIN ALCOHOLS | Meiji Dairies Corporation (JP) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004087630-A1 | PROCESS FOR PRODUCING CYCLOHEXENONE LONG-CHAIN ALCOHOLS | MEIJI DAIRIES CORPORATION (JP) | 2004-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135818-A1 | Process for producing cyclohexenone long-chain alcohols | ADH1C, ADH1A, HACD2 | ACHE 3012/4885NPC1 2446/4885RAB9A 4300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.